Early-stage clear cell ovarian cancer compared to high-grade histological subtypes: An outcome exploratory analysis in two oncology centers-Reference-Cited by-同舟云学术

Early-stage clear cell ovarian cancer compared to high-grade histological subtypes: An outcome exploratory analysis in two oncology centers

Published:2021-01 Issue:1 Volume:160 Page:64-70
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Ceppi Lorenzo,Grassi Tommaso,Galli Francesca,Buda Alessandro,Aletti Giovanni,Lissoni Andrea Alberto,Adorni Marco,Garbi Annalisa,Colombo Nicoletta,Bonazzi Cristina,Landoni Fabio,Fruscio Robert

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference40 articles.

1. Ovarian cancer statistics, 2018;Torre;CA Cancer J. Clin.,2018

2. Prognostic relevance of uncommon ovarian histology in women with stage III/IV epithelial ovarian cancer;Mackay;Int. J. Gynecol. Cancer,2010

3. Clinical characteristics of clear cell carcinoma of the ovary: A distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy;Sugiyama;Cancer,2000

4. Advanced stage clear-cell epithelial ovarian cancer: The Hellenic cooperative oncology group experience;Pectasides;Gynecol. Oncol.,2006

5. Integrated genomic analyses of ovarian carcinoma;Bell;Nature,2011

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nicotinamide N-methyltransferase enhances paclitaxel resistance in ovarian clear cell carcinoma;2024-04-25

2. Endometriosis-Related Ovarian Cancers: Evidence for a Dichotomy in the Histogenesis of the Two Associated Histotypes;Diagnostics;2023-04-15

3. The Significance of Radiotherapy in Ovarian Clear Cell Carcinoma: A Systematic Review and Meta-Analysis;Cancer Control;2023-04

4. Development and external validation of nomograms for predicting individual survival in patients with ovarian clear cell carcinoma;Cancer Medicine;2023-03-27

5. Shifting incidence and survival of epithelial ovarian cancer (1995‐2014): A SurvMark ‐2 study;International Journal of Cancer;2023-01-23